| 1 |
33332718 | Salvianolate ameliorates oxidative stress and podocyte injury through modulation of NOX4 activity in db/db mice. | 2021 Jan |
1 |
| 2 |
29491408 | Nox4 is a Target for Tuberin Deficiency Syndrome. | 2018 Feb 28 |
1 |
| 3 |
30018168 | Megakaryocytic Leukemia 1 Bridges Epigenetic Activation of NADPH Oxidase in Macrophages to Cardiac Ischemia-Reperfusion Injury. | 2018 Dec 11 |
1 |
| 4 |
30571757 | The Nox1/Nox4 inhibitor attenuates acute lung injury induced by ischemia-reperfusion in mice. | 2018 |
1 |
| 5 |
28160092 | Combined NOX1/4 inhibition with GKT137831 in mice provides dose-dependent reno- and atheroprotection even in established micro- and macrovascular disease. | 2017 May |
2 |
| 6 |
26445208 | The Nox1/4 Dual Inhibitor GKT137831 or Nox4 Knockdown Inhibits Angiotensin-II-Induced Adult Mouse Cardiac Fibroblast Proliferation and Migration. AT1 Physically Associates With Nox4. | 2016 May |
3 |
| 7 |
26222337 | Deficiency of NOX1 or NOX4 Prevents Liver Inflammation and Fibrosis in Mice through Inhibition of Hepatic Stellate Cell Activation. | 2015 |
1 |
| 8 |
24511132 | Genetic targeting or pharmacologic inhibition of NADPH oxidase nox4 provides renoprotection in long-term diabetic nephropathy. | 2014 Jun |
1 |
| 9 |
22618020 | Liver fibrosis and hepatocyte apoptosis are attenuated by GKT137831, a novel NOX4/NOX1 inhibitor in vivo. | 2012 Jul 15 |
1 |
| 10 |
22806357 | Nicotinamide adenine dinucleotide phosphate oxidase in experimental liver fibrosis: GKT137831 as a novel potential therapeutic agent. | 2012 Dec |
1 |